SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SirWalterRalegh who wrote (765421)7/20/2022 12:31:28 PM
From: skinowski1 Recommendation

Recommended By
Thomas M.

   of 794009
 
My favorites was the study conducted in Brazil (JAMA) - when very sick patients in ICU were given very high, toxic doses of HCQ. The medication “failed” - because more people on HCQ died than without it. The “idea” was that in vitro, it took extremely high doses to kill the virus. Any med student knows that medications in a bottle may behave differently than in the body. This one was used successfully for many decades.

Last I heard, the Gov of Brazil started a criminal investigation of that study.

A similar study was published in The Lancet.

Neither publication withdrew the study, despite criticisms.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News